Targeting the CD47-SIRPalpha checkpoint in multiple myeloma

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances2025
2. 2Progress in targeting tumor-associated macrophages in cancer immunotherapy2025 · 41 citations
3. 3Targeting myeloid cells to improve cancer immune therapy2025
4. 4CD43 functions as a CD47 independent “don't eat me” signal and novel immune checkpoint in AML2025
5. 5Abstract P60: CD47 in Osteosarcoma: Correlation with Metastasis and Macrophage-Mediated Phagocytosis2025